Simone Ferrero

Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy

Analysis of SARS-CoV-2 vertical transmission during pregnancy

Multiple myeloma

Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Artificial Intelligence in Cardiology

Diffuse large B-cell lymphoma

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma

Stimulatory and Inhibitory Analogs of Luteinizing Hormone Releasing Hormone (LHRH)

Neue Ziele für die Photopharmakologie

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Mechanisms of Diabetic Complications

Emerging Targets in Photopharmacology

The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice

Multiple Myeloma

Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles

Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro.

Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study

Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells

Radioimmunotherapy In Relapsed/Refractory Mantle Cell Lymphoma Patients: Final Results Of a European MCL Network Phase II Trial

Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?